Xiaoling Cockcroft

2.0k total citations
15 papers, 1.3k citations indexed

About

Xiaoling Cockcroft is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Xiaoling Cockcroft has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Xiaoling Cockcroft's work include Cancer therapeutics and mechanisms (6 papers), DNA Repair Mechanisms (5 papers) and PARP inhibition in cancer therapy (4 papers). Xiaoling Cockcroft is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), DNA Repair Mechanisms (5 papers) and PARP inhibition in cancer therapy (4 papers). Xiaoling Cockcroft collaborates with scholars based in United Kingdom, Austria and Switzerland. Xiaoling Cockcroft's co-authors include Keith Menear, Graeme C.M. Smith, Mark J. O’Connor, Niall M.B. Martin, Frank Kerrigan, Laurent Rigoreau, Sylvie Gomez, Ian T.W. Matthews, Mark Frigerio and Charlotte Knights and has published in prestigious journals such as Journal of Medicinal Chemistry, Chemistry - A European Journal and Molecular Cancer Therapeutics.

In The Last Decade

Xiaoling Cockcroft

15 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Cockcroft United Kingdom 11 857 717 326 118 99 15 1.3k
Keith Menear United Kingdom 17 1.1k 1.3× 778 1.1× 393 1.2× 122 1.0× 133 1.3× 32 1.6k
Gui‐Dong Zhu United States 20 695 0.8× 563 0.8× 490 1.5× 78 0.7× 122 1.2× 42 1.4k
Carsten Schultz‐Fademrecht Germany 20 804 0.9× 452 0.6× 469 1.4× 66 0.6× 64 0.6× 38 1.2k
Sylvie Gomez United Kingdom 6 532 0.6× 461 0.6× 171 0.5× 111 0.9× 94 0.9× 6 825
Lan-Zhen Wang United Kingdom 14 553 0.6× 520 0.7× 172 0.5× 71 0.6× 57 0.6× 16 899
Karen S. Flatten United States 24 1.4k 1.7× 814 1.1× 97 0.3× 49 0.4× 167 1.7× 45 1.9k
Elaine Willmore United Kingdom 23 1.4k 1.6× 778 1.1× 208 0.6× 28 0.2× 99 1.0× 54 1.7k
Jamin D. Steffen United States 11 618 0.7× 737 1.0× 59 0.2× 217 1.8× 161 1.6× 16 975
Yanke Liang United States 16 1.3k 1.5× 646 0.9× 181 0.6× 29 0.2× 50 0.5× 23 1.7k
Hariprasad Vankayalapati United States 21 1.5k 1.8× 257 0.4× 280 0.9× 25 0.2× 227 2.3× 61 2.2k

Countries citing papers authored by Xiaoling Cockcroft

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Cockcroft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Cockcroft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Cockcroft more than expected).

Fields of papers citing papers by Xiaoling Cockcroft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Cockcroft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Cockcroft. The network helps show where Xiaoling Cockcroft may publish in the future.

Co-authorship network of co-authors of Xiaoling Cockcroft

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Cockcroft. A scholar is included among the top collaborators of Xiaoling Cockcroft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Cockcroft. Xiaoling Cockcroft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bergner, Andreas, Xiaoling Cockcroft, Gerhard W. Fischer, et al.. (2019). KRAS Binders Hidden in Nature. Chemistry - A European Journal. 25(52). 12037–12041. 16 indexed citations
2.
Geist, Leonhard, Moriz Mayer, Xiaoling Cockcroft, et al.. (2017). Direct NMR Probing of Hydration Shells of Protein Ligand Interfaces and Its Application to Drug Design. Journal of Medicinal Chemistry. 60(21). 8708–8715. 23 indexed citations
3.
Cano, Céline, Olivier Barbeau, C. L. Bailey, et al.. (2010). DNA-Dependent Protein Kinase (DNA-PK) Inhibitors. Synthesis and Biological Activity of Quinolin-4-one and Pyridopyrimidin-4-one Surrogates for the Chromen-4-one Chemotype. Journal of Medicinal Chemistry. 53(24). 8498–8507. 35 indexed citations
4.
Golding, Sarah E., Elizabeth Rosenberg, Nicholas C.K. Valerie, et al.. (2009). Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion. Molecular Cancer Therapeutics. 8(10). 2894–2902. 285 indexed citations
5.
Menear, Keith, Sylvie Gomez, Karine Malagu, et al.. (2009). Identification and optimisation of novel and selective small molecular weight kinase inhibitors of mTOR. Bioorganic & Medicinal Chemistry Letters. 19(20). 5898–5901. 51 indexed citations
6.
Menear, Keith, Xiaoling Cockcroft, Aaron Cranston, et al.. (2008). 4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1. Journal of Medicinal Chemistry. 51(20). 6581–6591. 483 indexed citations
8.
Cockcroft, Xiaoling, et al.. (2006). Phthalazinones 2: Optimization and Synthesis of Novel Potent Inhibitors of Poly(ADP‐Ribose)polymerase.. ChemInform. 37(21). 4 indexed citations
9.
Cockcroft, Xiaoling, Sylvie Gomez, Frank Kerrigan, et al.. (2005). Phthalazinones. Part 1: The design and synthesis of a novel series of potent inhibitors of poly(ADP-ribose)polymerase. Bioorganic & Medicinal Chemistry Letters. 15(9). 2235–2238. 79 indexed citations
10.
Cockcroft, Xiaoling, et al.. (2005). Phthalazinones 2: Optimisation and synthesis of novel potent inhibitors of poly(ADP-ribose)polymerase. Bioorganic & Medicinal Chemistry Letters. 16(4). 1040–1044. 70 indexed citations
11.
Hardcastle, Ian R., Xiaoling Cockcroft, Nicola J. Curtin, et al.. (2005). Discovery of Potent Chromen-4-one Inhibitors of the DNA-Dependent Protein Kinase (DNA-PK) Using a Small-Molecule Library Approach. Journal of Medicinal Chemistry. 48(24). 7829–7846. 137 indexed citations
12.
Wang, Shouming, Adrian Folkes, Irina Chuckowree, et al.. (2004). Studies on Pyrrolopyrimidines as Selective Inhibitors of Multidrug-Resistance- Associated Protein in Multidrug Resistance. Journal of Medicinal Chemistry. 47(6). 1329–1338. 69 indexed citations
13.
Kane, Peter D., Keith Menear, Ric N. Price, et al.. (2000). the design and synthesis of thrombin inhibitors: the introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(14). 1567–1570. 9 indexed citations
14.
Brundish, Derek E., C. P. Dell, Peter D. Kane, et al.. (2000). The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position. Bioorganic & Medicinal Chemistry Letters. 10(14). 1563–1566. 8 indexed citations
15.
Ambler, John, Xiaoling Cockcroft, Markus G. Grütter, et al.. (1999). Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: Ion-dipole interactions with lysine 60G. Bioorganic & Medicinal Chemistry Letters. 9(9). 1317–1322. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026